In the last trading session, 11.47 million Citius Oncology Inc (NASDAQ:CTOR) shares changed hands as the company’s beta touched 1.58. With the company’s per share price at $4.5 changed hands at $1.0 or 28.57% during last session, the market valuation stood at $321.99M. CTOR’s last price was a discount, traded about -988.89% off its 52-week high of $49.00. The share price had its 52-week low at $0.55, which suggests the last value was 87.78% up since then. When we look at Citius Oncology Inc’s average trading volume, we note the 10-day average is 4.79 million shares, with the 3-month average coming to 2.03 million.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Instantly CTOR was in green as seen at the end of in last trading. With action 71.10%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -60.28%, with the 5-day performance at 71.10% in the green. However, in the 30-day time frame, Citius Oncology Inc (NASDAQ:CTOR) is 403.36% up. Looking at the short shares, we see there were 0.11 million shares sold at short interest cover period of 0.17 days.

The 2025 estimates are for Citius Oncology Inc earnings to decrease by -54.84%.

CTOR Dividends

Citius Oncology Inc is expected to release its next quarterly earnings report on 2025-May-14.

Citius Oncology Inc (NASDAQ:CTOR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 95.08% of Citius Oncology Inc shares while 0.76% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 15.38%.